|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q51677763
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010720.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q51677763
|
|
024
|
|
|
‡a
0000-0002-5832-4740
‡2
orcid
|
|
024
|
|
|
‡a
7005636664
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q51677763
|
|
100
|
0 |
|
‡a
Enrica De Rosa
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Enrica De Rosa
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Enrica De Rosa
‡c
investigadora
‡9
ast
|
|
400
|
0 |
|
‡a
Enrica De Rosa
‡c
ricercatrice
‡9
it
|
|
400
|
0 |
|
‡a
Enrica De Rosa
‡c
investigadora
‡9
es
|
|
670
|
|
|
‡a
Author's A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery.
|
|
670
|
|
|
‡a
Author's Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system
|
|
670
|
|
|
‡a
Author's Biodegradable nanoneedles for localized delivery of nanoparticles in vivo: exploring the biointerface
|
|
670
|
|
|
‡a
Author's Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization.
|
|
670
|
|
|
‡a
Author's Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.
|
|
670
|
|
|
‡a
Author's Biomimetic proteolipid vesicles for targeting inflamed tissues
|
|
670
|
|
|
‡a
Author's Correction to Biodegradable Nanoneedles for Localized Delivery of Nanoparticles in Vivo: Exploring the Biointerface.
|
|
670
|
|
|
‡a
Author's Effects of fibronectin and laminin on structural, mechanical and transport properties of 3D collageneous network.
|
|
670
|
|
|
‡a
Author's Enabling individualized therapy through nanotechnology
|
|
670
|
|
|
‡a
Author's Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases
|
|
670
|
|
|
‡a
Author's Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB.
|
|
670
|
|
|
‡a
Author's Leveraging nanochannels for universal, zero-order drug delivery in vivo
|
|
670
|
|
|
‡a
Author's Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor Chemotherapy
|
|
670
|
|
|
‡a
Author's Phosphoprotein-based biomarkers as predictors for cancer therapy
|
|
670
|
|
|
‡a
Author's PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins
|
|
670
|
|
|
‡a
Author's Soft Discoidal Polymeric Nanoconstructs Resist Macrophage Uptake and Enhance Vascular Targeting in Tumors.
|
|
670
|
|
|
‡a
Author's Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
|
|
909
|
|
|
‡a
(orcid) 0000000258324740
‡9
1
|
|
909
|
|
|
‡a
(scopus) 7005636664
‡9
1
|
|
919
|
|
|
‡a
leveragingnanochannelsforuniversal0orderdrugdeliveryinvivo
‡A
Leveraging nanochannels for universal, zero-order drug delivery in vivo
‡9
1
|
|
919
|
|
|
‡a
robustnanofluidicmembranewithtunable0orderreleaseforimplantabledosespecificdrugdelivery
‡A
A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery.
‡9
1
|
|
919
|
|
|
‡a
agarosesurfacecoatinginfluencesintracellularaccumulationandenhancespayloadstabilityofananodeliverysystem
‡A
Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system
‡9
1
|
|
919
|
|
|
‡a
unveilingtheinvivoproteincoronaofcirculatingleukocytelikecarriers
‡A
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
‡9
1
|
|
919
|
|
|
‡a
softdiscoidalpolymericnanoconstructsresistmacrophageuptakeandenhancevasculartargetingintumors
‡A
Soft Discoidal Polymeric Nanoconstructs Resist Macrophage Uptake and Enhance Vascular Targeting in Tumors.
‡9
1
|
|
919
|
|
|
‡a
plgamesoporoussiliconmicrospheresfortheinvivocontrolledtemporospatialdeliveryofproteins
‡A
PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins
‡9
1
|
|
919
|
|
|
‡a
biodegradablenanoneedlesforlocalizeddeliveryofnanoparticlesinvivoexploringthebiointerface
‡A
Biodegradable nanoneedles for localized delivery of nanoparticles in vivo: exploring the biointerface
‡9
1
|
|
919
|
|
|
‡a
phosphoproteinbasedbiomarkersaspredictorsforcancertherapy
‡A
Phosphoprotein-based biomarkers as predictors for cancer therapy
‡9
1
|
|
919
|
|
|
‡a
biomimeticproteolipidvesiclesfortargetinginflamedtissues
‡A
Biomimetic proteolipid vesicles for targeting inflamed tissues
‡9
1
|
|
919
|
|
|
‡a
correctiontobiodegradablenanoneedlesforlocalizeddeliveryofnanoparticlesinvivoexploringthebiointerface
‡A
Correction to Biodegradable Nanoneedles for Localized Delivery of Nanoparticles in Vivo: Exploring the Biointerface.
‡9
1
|
|
919
|
|
|
‡a
enhancingvascularizationthroughthecontrolledreleaseofplateletderivedgrowthfactorbb
‡A
Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB.
‡9
1
|
|
919
|
|
|
‡a
biodegradablesiliconnanoneedlesdeliveringnucleicacidsintracellularlyinducelocalizedinvivoneovascularization
‡A
Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization.
‡9
1
|
|
919
|
|
|
‡a
engineeredbiomimeticnanovesiclesshowintrinsicantiinflammatorypropertiesforthetreatmentofinflammatoryboweldiseases
‡A
Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases
‡9
1
|
|
919
|
|
|
‡a
liposomeembeddingsiliconmicroparticleforoxaliplatindeliveryintumorchemotherapy
‡A
Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor Chemotherapy
‡9
1
|
|
919
|
|
|
‡a
effectsoffibronectinandlamininonstructuralmechanicalandtransportpropertiesof3dcollageneousnetwork
‡A
Effects of fibronectin and laminin on structural, mechanical and transport properties of 3D collageneous network.
‡9
1
|
|
919
|
|
|
‡a
biomimeticcarriersmimickingleukocyteplasmamembranetoincreasetumorvasculaturepermeability
‡A
Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.
‡9
1
|
|
919
|
|
|
‡a
enablingindividualizedtherapythroughnanotechnology
‡A
Enabling individualized therapy through nanotechnology
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000460255515
|
|
996
|
|
|
‡2
ISNI|0000000054751417
|
|
996
|
|
|
‡2
PTBNP|600316
|
|
996
|
|
|
‡2
BAV|495_253639
|
|
996
|
|
|
‡2
BNF|14775008
|
|
996
|
|
|
‡2
BLBNB|001463318
|
|
996
|
|
|
‡2
SUDOC|234754583
|
|
996
|
|
|
‡2
JPG|500229966
|
|
996
|
|
|
‡2
NTA|183564278
|
|
996
|
|
|
‡2
ISNI|0000000068716049
|
|
996
|
|
|
‡2
DNB|1169846629
|
|
996
|
|
|
‡2
LC|n 2020055457
|
|
996
|
|
|
‡2
ISNI|0000000068174294
|
|
996
|
|
|
‡2
BIBSYS|6002708
|
|
996
|
|
|
‡2
SUDOC|245152326
|
|
996
|
|
|
‡2
LC|nr 93017663
|
|
996
|
|
|
‡2
ISNI|0000000117684929
|
|
996
|
|
|
‡2
PTBNP|1046743
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
